I agree that this site is using cookies. You can find further informations here.
X
Vaishampayan, Ulka
371  results:
Search for persons X
?
1

Adjuvant Everolimus in Patients with Completely Resected, V..:

Lara Jr, Primo N. ; Tangen, Catherine ; Heath, Elisabeth I....
European Urology.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Development of an orally bioavailable mSWI/SNF ATPase degra..:

He, Tongchen ; Cheng, Caleb ; Qiao, Yuanyuan...
Proceedings of the National Academy of Sciences.  121 (2024)  15 - p. , 2024
Link: https://doi.org/10.1073/..
 
?
3

Characterization of Responses to Lenvatinib plus Pembrolizu..:

Motzer, Robert J. ; Choueiri, Toni K. ; Hutson, Thomas...
European Urology.  86 (2024)  1 - p. 4-9 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Phase II Trial of Concurrent Nivolumab and Radiation Therap..:

Vaishampayan, Ulka N. ; Heilbrun, Lance ; Vaishampayan, Nitin...
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. 1472-1480 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Extragonadal germ cell tumors: A clinicopathologic study wi..:

Abdulfatah, Eman ; Brown, Noah A. ; Davenport, Matthew S....
Human Pathology.  148 (2024)  - p. 41-50 , 2024
Link: https://doi.org/10.1016/..
 
?
6

A global phase II randomized trial comparing oral taxane Mo..:

Vaishampayan, Ulka N. ; Keessen, Marianne ; Dreicer, Robert...
European Journal of Cancer.  202 (2024)  - p. 114007 , 2024
Link: https://doi.org/10.1016/..
 
?
7

SWOG S1931 (PROBE): PHASE III RANDOMIZED TRIAL OF IMMUNE CH..:

Kim, Hyung ; Tangen, Catherine M. ; Vaishampayan, Ulka...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S4 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Novel Approaches with HIF-2α Targeted Therapies in Metastat..:

Nguyen, Charles B. ; Oh, Eugene ; Bahar, Piroz...
Cancers.  16 (2024)  3 - p. 601 , 2024
Link: https://doi.org/10.3390/..
 
?
9

Race-Related Differences in Sipuleucel-T Response among Men..:

Heath, Elisabeth I. ; Thakur, Archana ; Chen, Wei...
Cancer Research Communications.  4 (2024)  7 - p. 1715-1725 , 2024
Link: https://doi.org/10.1158/..
 
?
10

Prevalence of Dietary Modification and Supplement Use in Pa..:

Ebrahimi, Hedyeh ; Battle, Dena ; Salgia, Nicholas J....
Nutrients.  16 (2024)  11 - p. 1630 , 2024
Link: https://doi.org/10.3390/..
 
?
11

A phase Ib study evaluating the recommended phase II dose, ..:

Juric, Dejan ; Barve, Minal ; Vaishampayan, Ulka...
Cancer Medicine.  13 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
12

Current Landscape of Genomic Biomarkers in Clear Cell Renal..:

Cotta, Brittney H. ; Choueiri, Toni K. ; Cieslik, Marcin...
European Urology.  84 (2023)  2 - p. 166-175 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Correction to: A Phase 1B open-label study of gedatolisib (..:

Curigliano, Giuseppe ; Shapiro, Geoffrey I. ; Kristeleit, Rebecca S....
British Journal of Cancer.  128 (2023)  2 - p. 400-400 , 2023
Link: https://doi.org/10.1038/..
 
?
14

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prost..:

Govindarajan, Barani ; Sbrissa, Diego ; Pressprich, Mark...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
15

Analysis of the Tumor Immune Microenvironment (TIME) in Cle..:

Farha, Mark ; Nallandhighal, Srinivas ; Vince, Randy...
Cancers.  15 (2023)  23 - p. 5530 , 2023
Link: https://doi.org/10.3390/..
 
1-15